A human beta-endorphin pituitary adenoma.

Area of Science:

• Endocrinology
• Neuroendocrinology
• Oncology

Background:

• Pituitary adenomas can secrete various hormones, leading to diverse clinical manifestations.
• Proopiomelanocortin (POMC) is a precursor peptide cleaved into several biologically active hormones, including ACTH and beta-endorphin.
• Understanding the specific peptide content of pituitary adenomas is crucial for diagnosis and treatment.

Observation:

• A 43-year-old male presented with impotence, testicular atrophy, and an enlarged sella turcica, but not Cushing's disease.
• Preoperative hormonal analysis revealed hyperprolactinemia, suppressed cortisol with no circadian rhythm, undetectable ACTH, and impaired gonadotropin response.
• Immunocytochemical, biochemical, and ultrastructural analyses confirmed a pituitary adenoma containing beta-endorphin (beta END).

Findings:

• The pituitary adenoma cells predominantly secreted beta END, with 30% of tumor cells reacting to beta END antiserum.
• Radioimmunoassay (RIA) and gel electrophoresis confirmed beta END as the sole detectable peptide secreted by the tumor.
• Post-hypophysectomy, the patient's hormonal levels normalized and responded appropriately to dynamic testing.

Implications:

• The findings demonstrate a dissociation in the secretion of proopiomelanocortin (POMC)-derived peptides from this specific pituitary adenoma.
• This case suggests a potential relationship between hyperprolactinemia and the tumor's secretion of beta-endorphin.
• Further research into POMC-derived peptide secretion in pituitary tumors may reveal new diagnostic and therapeutic targets.